ClinicalTrials.Veeva

Menu

Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19

B

Biruni University

Status

Completed

Conditions

Covid19
Fatigue
Menstrual Problem

Treatments

Other: A survey of 60 questions was created through the internet-based 'Google Forms surveys' site.

Study type

Observational

Funder types

Other

Identifiers

NCT04806815
2021/47-45

Details and patient eligibility

About

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. The aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

Full description

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. It has been examined that menstruation volume decreased or cycle lengthened in one-fifth of women who had COVID-19, and this condition was more intense in those who had severe COVID-19. Studies have shown that the possible effects of COVID-19 on the female genital system often remain theoretical hypotheses. In the literature, there was no study in which menstrual dysfunctions and secondary problems caused by the state of inactivity entering our lives during pandemic were discussed in a wide spectrum of women who had COVID-19. Therefore the aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

Enrollment

180 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being between the ages of 18 and 45,
  • PCR test result positive confirmed having COVID-19 infection,
  • Women had at least one period of Menstrual cycle after COVID-19
  • Being an Internet connection,
  • To be able to speak and write in Turkish.

Exclusion criteria

  • To be in the premenaposual/postmenopausal period (to be in the transition period to menopause or in the period after menopause.)
  • Having insufficient co-operation.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems